Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAIR-Pilot: FFR-guided Renal Artery Stenting
NCT05732077Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jan 2023
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Peking University First Hospital. Primary endpoints: Change in daytime mean systolic blood pressure at 3 months and Change in the composite index of antihypertensive drugs at 3 months. Started Jan 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05732077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05732077.